Clarivate Plc
NYSE:CLVTInformation Technology Services
-$0.10 today
- Market cap
- $1.40B
- Beta
- 1.37
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$0.21
Volume 3.00M
Average 5.22M
CLVT EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Clarivate PlcNYSE: CLVT
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA dips below year-ago levels
Q1 FY2026 EBITDA of $214.2M fell 1.0% year over year, behind the +92.2% change in trailing-twelve-month EBITDA. Sequentially, it fell 7.1% from the prior quarter.
Context
- EBITDA amounted to 33.8% of revenue in FY2025, up 15.9 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 6 analysts of $1.57B (+89.3%) for the fiscal year ending Dec 2026, a step up from the +81.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $214.2M-7.1% QoQ
- Last fiscal yearDec 2025
- $828.7M+81.5% YoY
- LTMMar 2026
- $929.1M+92.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -1.0% | +58.4% | +59.4 pp |
| 1 year | +81.5% | +89.3% | +7.8 pp |
| 3-year CAGR | — | +17.9% | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 828.7M USD
- Year-over-year change
- +81.5%
- 4-year CAGR
- +11.7%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 828.7M | +81.5% |
| FY2024 | 2024-12-31 | 456.6M | +4448.6% |
| FY2023 | 2023-12-31 | (10.5M) | +99.7% |
| FY2022 | 2022-12-31 | (3.01B) | -665.3% |
| FY2021 | 2021-12-31 | 532.16M | — |
EBITDA vs competitors
How CLVT compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +92.2% is the highest of 10, against a peer median of -6.9%.
- EBITDA amounts to 38.0% of revenue for CLVT, versus a peer median of 13.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CN¥3.66B CNY | +54.9% | +33.5% | 35.4% | |
| LTM Sep 2026 | $1.5B USD | -30.4% | +25.1% | 12.1% | |
| LTM Mar 2026 | $929.1M USD | +92.2% | — | 38.0% | |
| LTM Mar 2026 | $375.49M USD | +39.5% | -4.8% | 12.9% | |
| LTM Mar 2026 | $340.54M USD | -6.9% | -1.7% | 13.9% | |
| LTM Mar 2026 | $128.83M USD | +16.8% | — | 9.9% | |
| LTM Jun 2026 | $67.81M USD | +44.4% | — | 21.4% | |
| LTM Mar 2026 | -$256.49M USD | -701.5% | — | 201.4% | |
| LTM Feb 2026 | -$305.24M USD | -123.1% | — | 3.1% | |
| LTM Apr 2026 | -$459.33M USD | -67.0% | — | 183.5% | |
| Peer median (excluding CLVT) | — | -6.9% | +11.7% | 13.9% | |
Competitors are the stored peer set for CLVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.88B | 2.66B | 2.63B | 2.56B | 2.46B |
| Cost of Revenue | 626.1M | 954M | 906.4M | 869.2M | 833.6M |
| Gross Profit | 1.25B | 1.71B | 1.72B | 1.69B | 1.62B |
| Gross Margin | 66.6% | 64.1% | 65.5% | 66.0% | 66.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 643M | 729.9M | 739.7M | 727.6M | 708.6M |
| Operating Expenses | 1.34B | 5.63B | 2.46B | 1.96B | 1.55B |
| Depreciation & Amortization | 537.8M | 710.5M | 708.3M | 727M | 757.2M |
| EBITDA | 532.16M | (3.01B) | (10.5M) | 456.6M | 828.7M |
| EBITDA Margin | 28.4% | -113.1% | -0.4% | 17.9% | 33.8% |
| Operating Income | (87M) | (3.93B) | (734.7M) | (275.6M) | 71.5M |
| Operating Margin | -4.6% | -147.6% | -27.9% | -10.8% | 2.9% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 252.5M | 270.3M | 293.7M | 283.4M | 265.4M |
| Other Income / Expenses | (171.2M) | (63.5M) | (277.8M) | (278.2M) | (265.4M) |
| Income Before Tax | (258.2M) | (3.99B) | (1.01B) | (553.8M) | (193.9M) |
| Pre-Tax Margin | -13.8% | -150.0% | -38.5% | -21.7% | -7.9% |
| Income Tax Expense | 12.3M | (28.9M) | (101.3M) | 82.9M | 7.2M |
| Net Income | (270.5M) | (3.96B) | (911.2M) | (636.7M) | (201.1M) |
| Net Margin | -14.4% | -148.9% | -34.7% | -24.9% | -8.2% |
| EPS (Basic) | (0.62) | (6.26) | (1.47) | (0.96) | (0.30) |
| EPS (Diluted) | (0.61) | (6.24) | (1.47) | (0.96) | (0.30) |
| Weighted Avg Shares | 630.98M | 676.1M | 671.6M | 693.6M | 673.3M |
| Weighted Avg Shares (Diluted) | 640.77M | 678.6M | 671.6M | 693.6M | 673.3M |
Clarivate Plc
NYSE:CLVT
Intrinsic Alpha fair value
Locked
Current Price
$2.19
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.